Some middle-aged women may think they have waited too long to reduce their risk of stroke by adopting a healthier lifestyle—that it is too late for such a change to make an impact.

The American Medical Association (AMA) has published two new documents designed to help physicians affected by the ongoing COVID-19 pandemic.

One cardiologist is sharing his own experience with the new coronavirus to try and help others understand it can be beaten. 

Women are at an increased risk of adverse events following percutaneous coronary intervention (PCI), according to new findings published in the Journal of the American College of Cardiology.

Healthcare providers should use caution when considering the treatment of COVID-19 patients with hydroxychloroquine and azithromycin if the patients have cardiovascular disease.

A new international research study will focus on treatment strategies and outcomes of ST-segment elevation myocardial infarction (STEMI) patients with known or suspected COVID-19.

Warfarin use does not reduce the risk of stroke for end-stage renal disease (ESRD) patients with AFib, according to a new meta-analysis published in JAMA Network Open. It does, however, lead to an increased risk of hemorrhagic stroke.

A French hospital testing the effectiveness of hydroxychloroquine on COVID-19 patients had to immediately stop testing on one patient due to the risk of significant cardiac side effects.

U.S. hospitals are facing numerous challenges as they work to combat the continued spread of COVID-19, according to a new government survey of more than 300 hospital administrators.

As COVID-19 continues to keep healthcare providers busy, fewer patients appear to be seeking care for other serious issues, including cardiovascular complications such as heart attack and stroke.